Experts in dermatology discuss the pathophysiology of vitiligo, current standards of care, and new and emerging therapies. They also explore evidence-based approaches and patient-centered care to manage vitiligo and improve patient outcomes.
EP. 1: Prevalence of Vitiligo
Drs Brittany Craiglow and Nada Elbuluk review the precipitating factors that trigger vitiligo, as well as segmental vs nonsegmental vitiligo.
EP. 2: Assessment of Vitiligo Severity
Ted Lain, MD, breaks down the use of the Vitiligo Area Scoring Index calculations to assess vitiligo severity.
EP. 3: Quality of Life for Vitiligo Patients
Heather Woolery-Lloyd, MD, comments on the emotional impact of vitiligo on patients’ quality of life.
EP. 4: Treatment Goals in Vitiligo
Expert dermatologists share approaches to treating patients with vitiligo, focusing on patient communication and the use of combination therapy.
EP. 5: Mechanism of Repigmentation in Vitiligo
Ted Lain, MD, reviews the rates and patterns of repigmentation of the skin in vitiligo and how the timeline is different for each patient.
EP. 6: Measuring Vitiligo Treatment Response
Brittany Craiglow, MD, discusses the lengthy nature of vitiligo treatment response and how to approach communicating with patients who want to see change quickly.
EP. 7: Use of Ruxolitinib for Treatment of Vitiligo
Experts in dermatology review the mechanism of action and clinical trials of topical ruxolitinib for repigmenting the skin in vitiligo.
EP. 8: Impact of UV Light Exposure on Vitiligo
Expert dermatologists comment on the impact of UV light exposure on areas of the skin with vitiligo and their recommendations for sunscreen use.
EP. 9: Adverse Events of Ruxolitinib in Vitiligo Trials
Heather Woolery-Lloyd, MD, discusses the adverse event profile of topical ruxolitinib for treatment of vitiligo, highlighting the well-tolerated nature of the drug.
EP. 10: Treatment Approaches to Ruxolitinib in Vitiligo
Experts in dermatology share their impressions of ruxolitinib and approaches to vitiligo treatment in clinical practice.
EP. 11: Treatment Response to Conventional vs Emerging Therapies in Vitiligo
Nada Elbuluk, MD, and Ted Lain, MD, compare response to conventional treatment options vs emerging therapies, such as ruxolitinib, in the treatment of vitiligo.
EP. 12: Disease Burden for Patients With Vitiligo
Expert dermatologists discuss the impact of vitiligo and vitiligo treatment on quality of life.
EP. 13: Managing Vitiligo Patient Expectations
Heather Woolery-Lloyd, MD, and Nada Elbuluk, MD, share approaches to patient education and managing patient expectations when repigmenting the skin in vitiligo.
EP. 14: Promoting Access to New Therapies in Vitiligo
Experts in dermatology comment on the need to promote access to emerging treatments in vitiligo.
EP. 15: Key Takeaways on Vitiligo Management
Expert dermatologists share final thoughts on treatment of vitiligo and topical ruxolitinib.
2 Clarke Drive Cranbury, NJ 08512